Efficacy News and Research

RSS

Social media image about mask efficacy right in sentiment, but percentages are ‘bonkers’

A popular social media post that's been circulating on Instagram and Facebook since April depicts the degree to which mask-wearing interferes with the transmission of the novel coronavirus.

6 Jul 2020

Highly effective and safe nanocrystal can fight against dangerous doses of radiation

Despite the wide application of radiation in diagnostics and treatments, there is still no magic material to protect people from radiation exposure.

6 Jul 2020

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

A clinical viscosity diagnostic instrument is proving to be valuable in the research and treatment of coronavirus after laboratory scientists have identified its ability to provide meaningful data for medical teams treating Covid-19 patients.

3 Jul 2020

Bees-Haus method of cell therapy for treating urethral stricture receives Japanese patent

Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan.

3 Jul 2020

Pfizer/BioNTech COVID-19 vaccine shows promise - virus neutralizing antibodies achieved

In a recent medRxiv* paper, a research group from the U.S. and Germany showed a robust immunogenic response and a promising safety profile of the novel BNT162b1 RNA-based vaccine against coronavirus disease (COVID-19) – actively encouraging its accelerated clinical development and potential rapid production.

2 Jul 2020

Common chemotherapy drug may be less effective in overweight, obese breast cancer patients

Breast cancer patients who are overweight or obese might benefit less from treatment with docetaxel, a common chemotherapy drug, than lean patients.

2 Jul 2020

Controlled human infection models as a strategy to accelerate SARS-CoV-2 vaccine development

Infecting some volunteers with COVID-19 may provide valuable insights for future rounds of vaccine testing, but would require very strict controls, argues a group of infectious disease experts in the New England Journal of Medicine.

2 Jul 2020

Ceftolozane/tazobactam combo broadens the range of antibiotic therapy, but shows no hint of added benefit

The combination of ceftolozane with tazobactam broadens the range of antibiotic therapy in adults with severe infections of the lungs, the urinary tract, the renal pelvis and the abdominal cavity.

2 Jul 2020

Developing Vaccines and Therapeutics by Exploiting Structure in Spherical Nucleic Acids

An interview discussing the use of spherical nucleic acids (SNAs) and what they show about the importance of structure in pharmaceutical development.

From Pittcon 2 Jul 2020

ACTIV group assesses controlled human infection models for developing SARS-CoV-2 vaccine

In a Perspective for the New England Journal of Medicine, members of the National Institutes of Health's Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used for human challenge studies, to support SARS-CoV-2 vaccine development.

2 Jul 2020

How lockdown stopped the virus in Italy

Previous studies have shown that many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases were tied to asymptomatic carriers or those who do not manifest symptoms of the viral infection. Now, a new study reveals that in the first Italian town hit by the virus, as much as 40 percent of the population had no symptoms of the coronavirus disease (COVID-19).

1 Jul 2020

Scientists find coronavirus' Achilles' heel

A team of scientists at the University of California San Francisco has found out how SARS-CoV-2, the virus that causes the coronavirus disease (COVID-19) invades proteins in the cells that serve as master regulators of key cellular processes.

1 Jul 2020

Which facemasks work best at stopping coronavirus?

A new study shows how wearing masks can prevent the spread of droplet borne infections and is an excellent preventive measure to stop the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study titled, "Visualizing the effectiveness of face masks in obstructing respiratory jets," is published in the latest issue of the journal Physics of Fluids.

1 Jul 2020

New approach holds incredible potential for developing new therapeutics

Nearly every drug that is, or has ever been, used was derived from nature -- harnessing compounds created by organisms over eons to fight diseases. But decades ago, biochemists postulated that it might be possible to design a new drug from scratch by linking up amino acids in precise ways.

30 Jun 2020

Researchers develop technique for personalizing stomach cancer therapy

Researchers from the Moscow Institute of Physics and Technology and their colleagues have developed the first technique for personalizing stomach cancer therapy based on RNA sequencing of tumor cells. The study, supported by the Russian Science Foundation, was published in Cold Spring Harbor Molecular Case Studies.

30 Jun 2020

Glowing dye may illuminate tumors during surgery

"Clean margins" are a goal of cancer excision surgery. If even a small piece of cancerous tissue is left behind, it increases the likelihood of a local recurrence and spread of the disease, possibly reducing overall survival time.

30 Jun 2020

COVID-19 study in Italian town reveals the importance of asymptomatic cases

A study of COVID-19 in the quarantined Italian town of Vò, where most of the population was tested, reveals the importance of asymptomatic cases.

30 Jun 2020

A potential treatment for cardiac regeneration

New research gives information in order to understand safety, efficacy and mechanisms of action of a new cardiac therapy.

30 Jun 2020

Engineered immune cells attack solid-tumor cancer cells from humans and mice

A method known as CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

30 Jun 2020

Modified Vaccinia Ankara-based vaccine candidate for SARS-CoV-2

Now, a new study by researchers at Emory University, the University of Texas Medical Branch and the Ragon Institute and published on the preprint server bioRxiv in June 2020 reports the development of a promising new vaccine candidate that may rapidly and effectively induce the production of neutralizing antibodies against the spike protein of the virus.

30 Jun 2020

Efficacy News and Research

Social media image about mask efficacy right in sentiment, but percentages are ‘bonkers’

Highly effective and safe nanocrystal can fight against dangerous doses of radiation

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

Bees-Haus method of cell therapy for treating urethral stricture receives Japanese patent

Pfizer/BioNTech COVID-19 vaccine shows promise - virus neutralizing antibodies achieved

Common chemotherapy drug may be less effective in overweight, obese breast cancer patients

Controlled human infection models as a strategy to accelerate SARS-CoV-2 vaccine development

Ceftolozane/tazobactam combo broadens the range of antibiotic therapy, but shows no hint of added benefit

Developing Vaccines and Therapeutics by Exploiting Structure in Spherical Nucleic Acids

ACTIV group assesses controlled human infection models for developing SARS-CoV-2 vaccine

How lockdown stopped the virus in Italy

Scientists find coronavirus' Achilles' heel

Which facemasks work best at stopping coronavirus?

New approach holds incredible potential for developing new therapeutics

Researchers develop technique for personalizing stomach cancer therapy

Glowing dye may illuminate tumors during surgery

COVID-19 study in Italian town reveals the importance of asymptomatic cases

A potential treatment for cardiac regeneration

Engineered immune cells attack solid-tumor cancer cells from humans and mice

Modified Vaccinia Ankara-based vaccine candidate for SARS-CoV-2

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News